vs
Side-by-side financial comparison of ASGN Inc (ASGN) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $970.0M, roughly 1.6× ASGN Inc). ASGN Inc runs the higher net margin — 0.6% vs -13.6%, a 14.2% gap on every dollar of revenue. On growth, ASGN Inc posted the faster year-over-year revenue change (-3.0% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $9.1M). Over the past eight quarters, ASGN Inc's revenue compounded faster (-3.2% CAGR vs -3.6%).
ASGN Inc is a leading U.S.-headquartered professional services and workforce solutions provider. It specializes in supplying skilled talent and consulting services across high-growth segments including information technology, creative, digital, life sciences, and engineering, primarily serving enterprise clients across North America.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
ASGN vs OGN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $970.0M | $1.5B |
| Net Profit | $5.5M | $-205.0M |
| Gross Margin | 27.5% | 49.2% |
| Operating Margin | 2.9% | -9.8% |
| Net Margin | 0.6% | -13.6% |
| Revenue YoY | -3.0% | -5.3% |
| Net Profit YoY | -73.7% | -288.1% |
| EPS (diluted) | $0.13 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $970.0M | — | ||
| Q4 25 | $980.1M | $1.5B | ||
| Q3 25 | $1.0B | $1.6B | ||
| Q2 25 | $1.0B | $1.6B | ||
| Q1 25 | $968.3M | $1.5B | ||
| Q4 24 | $985.0M | $1.6B | ||
| Q3 24 | $1.0B | $1.6B | ||
| Q2 24 | $1.0B | $1.6B |
| Q1 26 | $5.5M | — | ||
| Q4 25 | $25.2M | $-205.0M | ||
| Q3 25 | $38.1M | $160.0M | ||
| Q2 25 | $29.3M | $145.0M | ||
| Q1 25 | $20.9M | $87.0M | ||
| Q4 24 | $42.4M | $109.0M | ||
| Q3 24 | $47.5M | $359.0M | ||
| Q2 24 | $47.2M | $195.0M |
| Q1 26 | 27.5% | — | ||
| Q4 25 | 28.9% | 49.2% | ||
| Q3 25 | 29.4% | 53.5% | ||
| Q2 25 | 28.7% | 54.8% | ||
| Q1 25 | 28.4% | 55.6% | ||
| Q4 24 | 29.0% | 56.3% | ||
| Q3 24 | 29.1% | 58.3% | ||
| Q2 24 | 29.1% | 58.4% |
| Q1 26 | 2.9% | — | ||
| Q4 25 | 5.7% | -9.8% | ||
| Q3 25 | 6.7% | 15.2% | ||
| Q2 25 | 5.8% | 14.4% | ||
| Q1 25 | 4.8% | 6.7% | ||
| Q4 24 | 7.5% | 8.1% | ||
| Q3 24 | 7.7% | 13.1% | ||
| Q2 24 | 7.8% | 14.6% |
| Q1 26 | 0.6% | — | ||
| Q4 25 | 2.6% | -13.6% | ||
| Q3 25 | 3.8% | 10.0% | ||
| Q2 25 | 2.9% | 9.1% | ||
| Q1 25 | 2.2% | 5.8% | ||
| Q4 24 | 4.3% | 6.8% | ||
| Q3 24 | 4.6% | 22.7% | ||
| Q2 24 | 4.6% | 12.1% |
| Q1 26 | $0.13 | — | ||
| Q4 25 | $0.58 | $-0.78 | ||
| Q3 25 | $0.87 | $0.61 | ||
| Q2 25 | $0.67 | $0.56 | ||
| Q1 25 | $0.48 | $0.33 | ||
| Q4 24 | $0.94 | $0.42 | ||
| Q3 24 | $1.06 | $1.38 | ||
| Q2 24 | $1.02 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $143.6M | $574.0M |
| Total DebtLower is stronger | $1.5B | $8.6B |
| Stockholders' EquityBook value | $1.8B | $752.0M |
| Total Assets | $4.0B | $12.9B |
| Debt / EquityLower = less leverage | 0.82× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $143.6M | — | ||
| Q4 25 | $161.2M | $574.0M | ||
| Q3 25 | — | $672.0M | ||
| Q2 25 | — | $599.0M | ||
| Q1 25 | — | $547.0M | ||
| Q4 24 | $205.2M | $675.0M | ||
| Q3 24 | — | $763.0M | ||
| Q2 24 | — | $704.0M |
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.2B | $8.6B | ||
| Q3 25 | $1.2B | $8.8B | ||
| Q2 25 | $1.2B | $8.9B | ||
| Q1 25 | $1.3B | $9.0B | ||
| Q4 24 | $1.0B | $8.9B | ||
| Q3 24 | $1.0B | $8.7B | ||
| Q2 24 | $1.0B | $8.7B |
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $752.0M | ||
| Q3 25 | $1.8B | $906.0M | ||
| Q2 25 | $1.8B | $733.0M | ||
| Q1 25 | $1.8B | $542.0M | ||
| Q4 24 | $1.8B | $472.0M | ||
| Q3 24 | $1.8B | $493.0M | ||
| Q2 24 | $1.8B | $144.0M |
| Q1 26 | $4.0B | — | ||
| Q4 25 | $3.7B | $12.9B | ||
| Q3 25 | $3.7B | $13.6B | ||
| Q2 25 | $3.7B | $13.5B | ||
| Q1 25 | $3.7B | $13.2B | ||
| Q4 24 | $3.4B | $13.1B | ||
| Q3 24 | $3.4B | $12.8B | ||
| Q2 24 | $3.5B | $12.2B |
| Q1 26 | 0.82× | — | ||
| Q4 25 | 0.65× | 11.49× | ||
| Q3 25 | 0.64× | 9.74× | ||
| Q2 25 | 0.66× | 12.14× | ||
| Q1 25 | 0.72× | 16.52× | ||
| Q4 24 | 0.58× | 18.81× | ||
| Q3 24 | 0.58× | 17.75× | ||
| Q2 24 | 0.57× | 60.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $141.0M |
| Free Cash FlowOCF − Capex | $9.1M | $96.0M |
| FCF MarginFCF / Revenue | 0.9% | 6.4% |
| Capex IntensityCapex / Revenue | 1.0% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $290.6M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $102.3M | $141.0M | ||
| Q3 25 | $83.9M | $264.0M | ||
| Q2 25 | $124.9M | $220.0M | ||
| Q1 25 | $16.8M | $75.0M | ||
| Q4 24 | $100.2M | $390.0M | ||
| Q3 24 | $135.8M | $141.0M | ||
| Q2 24 | $90.7M | $332.0M |
| Q1 26 | $9.1M | — | ||
| Q4 25 | $93.7M | $96.0M | ||
| Q3 25 | $72.0M | $218.0M | ||
| Q2 25 | $115.8M | $181.0M | ||
| Q1 25 | $6.6M | $43.0M | ||
| Q4 24 | $88.9M | $335.0M | ||
| Q3 24 | $127.9M | $99.0M | ||
| Q2 24 | $85.4M | $300.0M |
| Q1 26 | 0.9% | — | ||
| Q4 25 | 9.6% | 6.4% | ||
| Q3 25 | 7.1% | 13.6% | ||
| Q2 25 | 11.3% | 11.4% | ||
| Q1 25 | 0.7% | 2.8% | ||
| Q4 24 | 9.0% | 21.0% | ||
| Q3 24 | 12.4% | 6.3% | ||
| Q2 24 | 8.3% | 18.7% |
| Q1 26 | 1.0% | — | ||
| Q4 25 | 0.9% | 3.0% | ||
| Q3 25 | 1.2% | 2.9% | ||
| Q2 25 | 0.9% | 2.4% | ||
| Q1 25 | 1.1% | 2.1% | ||
| Q4 24 | 1.1% | 3.5% | ||
| Q3 24 | 0.8% | 2.7% | ||
| Q2 24 | 0.5% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.06× | — | ||
| Q3 25 | 2.20× | 1.65× | ||
| Q2 25 | 4.26× | 1.52× | ||
| Q1 25 | 0.80× | 0.86× | ||
| Q4 24 | 2.36× | 3.58× | ||
| Q3 24 | 2.86× | 0.39× | ||
| Q2 24 | 1.92× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
